All In Biotech

Drug Trial Radar · NCT03636204

A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin (GRN) Mutation

A First in Human Phase 1 Study in Healthy Volunteers and in Participants With Frontotemporal Dementia (FTD) With Granulin Mutation

Last checked: Nov 19, 2026Latest source record: Jul 27, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

64

Actual

Start

Sep 14, 2018

Primary completion

Dec 31, 2019

Study completion Dec 31, 2019

Sponsor

Lead sponsor
Alector Inc.Industry
Sponsor type
Industry
First posted
Aug 17, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A first in human phase 1 study in healthy volunteers and participants with Granulin (GRN) mutation causative of frontotemporal dementia (FTD) to assess AL001 safety, tolerability, pharmacokinetics, and pharmacodynamics

Conditions

  • Healthy
  • Frontotemporal Dementia

Interventions

  • AL001Biological

    Active dose of AL001

  • PlaceboOther

    Saline solution administered as a single infusion as palcebo.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluation of safety and tolerability of AL001 measured by number of subjects with adverse events and Dose Limiting Adverse Event (DLAEs)Time frame: 85 days

Locations

8 sites in 3 countries. Site status is shown where the registry gives one.

  • University of Alabama

    Birmingham, Alabama

  • UCSF

    San Francisco, California

  • Study site

    Orlando, Florida

  • Mayo Clinic

    Rochester, Minnesota

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Sunnybrook Health Sciences Centre

    Toronto, Canada

  • Lawson Health Research Institute, St. Joseph's

    London, Ontario, Canada

  • University College London

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.